health-news

'Alzheimer's drug to be developed within five years'

Washington, Dec. 5 : Scientists have said that a drug that could provide a breakthrough for Alzheimer's disease will be available within the next five years.


Recruitment of people aged 55 - 90 to take part in the final-stage study in the US is taking place. The study will examine if the drug solanezumab slows the cognitive and functional decline of people who suffer from mild Alzheimer's.

In the new trial expected to end by December 2016, people are going to be given solanezumab as a monthly 400mg injection for 18 months.

Dr Eric Karran, director of research at Alzheimer's Research UK, said that the results would suggest that monthly injections should be given early to ward off the disease, News.com.au reported.

Dr Karran said that the drug showed "reasonable" effect in people suffering from mild Alzheimer's and results would come within five years.

--ANI (Posted on 05-12-2013)

health-news headlines

Malnutrition not priority for most parties: CRY

Testosterone levels in womb may impact your health

Bone marrow can cure blood disorders

Heart's development doesn't stop with birth

Mothers! Take a break from fish for healthier babies

Pancreatic, biliary cancers difficult to treat: Experts

NHC showcase bone marrow transplant to cure blood disorders

Probiotic use for infant colic 'not effective in reducing symptoms'

Laugh your way to improved short-term memory

'Chaperone' compounds could help treat Alzheimer's

Source of most cases of invasive bladder cancer identified

Daytime napping may lead to early death: Study

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014

Comments

Your e-mail:


Your Full Name:


Type verification image:
verification image, type it in the box

Message:

Back to Top